Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Armata Pharmaceuticals, Inc. Director's Dealing 2008

Nov 17, 2008

34152_dirs_2008-11-17_1fde0e7a-67e1-4fba-b712-4cd3ba624b7d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2008-11-06

Reporting Person: Robinson BG Susan (President and CEO)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 66915 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock option (right to buy) $124.40 2010-04-03 Common stock (3500) Direct
Stock option (right to buy) $66.60 2011-01-23 Common stock (2000) Direct
Stock option (right to buy) $59.50 2011-05-08 Common stock (499) Direct
Stock option (right to buy) $25.70 2012-01-22 Common stock (3999) Direct
Stock option (right to buy) $7.60 2012-08-07 Common stock (999) Direct
Stock option (right to buy) $2.90 2013-02-18 Common stock (2500) Direct
Stock option (right to buy) $7.80 2003-05-08 Common stock (2000) Direct
Stock option (right to buy) $27.40 2014-01-16 Common stock (4999) Direct
Stock option (right to buy) $13.10 2014-05-20 Common stock (5000) Direct
Stock option (right to buy) $9.10 2015-05-26 Common stock (5000) Direct
Stock option (right to buy) $3.80 2016-06-12 Common stock (25000) Direct

Footnotes

F1: Represents (a) 8,582 shares, (b) 23,333 shares, which represent a grant of restricted stock units ("RSUs") that vest in two substantially equal installments on each of May 17, 2009 and May 17, 2010 (of the initial grant of 35,000 RSUs, 11,667 shares had vested and were released as of the date of this Form 3, of which 3,085 shares were withheld by the issuer in connection with the payment of withholding taxes on the vested shares), and (b) 35,000 shares, which represent a grant of RSUs that vest in three substantially equal installments on each of May 15, 2009, May 15, 2010 and May 15, 2011, so long as the reporting person is providing services to the issuer on such dates, which vesting will be accelerated upon the occurence of certain events.

F2: Option is fully vested and exercisable as of the date of filing this Form 3.

F3: Such option vests and is exercisable 6.25% quarterly, commencing August 26, 2005, with 100% vested and exercisable on May 26, 2009.